UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Synthesis and biological evaluation of imidazole-based small molecule antagonists of the melanocortin 4 receptor (MC4-R)

Bioorganic & medicinal chemistry letters, 2004-07, Vol.14 (14), p.3721-3725

2004

Volltextzugriff (PDF)

Identification of 2-{2-[2-(5-Bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1H-imidazole (ML00253764), a Small Molecule Melanocortin 4 Receptor Antagonist That Effectively Reduces Tumor-Induced Weight Loss in a Mouse Model

Journal of medicinal chemistry, 2004-03, Vol.47 (7), p.1602-1604

2004

Volltextzugriff (PDF)

Selective Tolyl Carbon Alkylation Mediated by Imidazoline-Directed Lithiation

Synthetic communications, 2004, Vol.34 (19), p.3455-3464

2004

Volltextzugriff (PDF)

Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model

Journal of medicinal chemistry, 2004-03, Vol.47 (7), p.1602-1604

2004

Volltextzugriff (PDF)

Identification of 2-{2-[2-(5-Bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1 H -imidazole (ML00253764), a Small Molecule Melanocortin 4 Receptor Antagonist That Effectively Reduces Tumor-Induced Weight Loss in a Mouse Model

Journal of medicinal chemistry, 2004-03, Vol.47 (7), p.1602-1604

2004

Volltextzugriff (PDF)

Identification of 2-{2-[2-(5-bromo-2-methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1H-imidazol e (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model

Journal of medicinal chemistry, 2004, Vol.47 (7), p.1602-1604

2004

Volltextzugriff (PDF)

Selective Tolyl Carbon Alkylation Mediated by Imidazoline-Directed Lithiation

ChemInform, 2005-02, Vol.36 (7), p.no-no

2005

Volltextzugriff (PDF)

Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size

Molecular psychiatry, 2020-08, Vol.25 (8), p.1822-1834

2020

Volltextzugriff (PDF)

Source‐based morphometry reveals structural brain pattern abnormalities in 22q11.2 deletion syndrome

Human brain mapping, 2024-01, Vol.45 (1), p.e26553-n/a

2024

Volltextzugriff (PDF)

Prioritizing Genetic Contributors to Cortical Alterations in 22q11.2 Deletion Syndrome Using Imaging Transcriptomics

Cerebral cortex (New York, N.Y. 1991), 2021-06, Vol.31 (7), p.3285-3298

2021

Volltextzugriff (PDF)

Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness

The American journal of psychiatry, 2020-07, Vol.177 (7), p.589-600

2020

Volltextzugriff (PDF)

Infection, vaccination, and childhood arterial ischemic stroke: Results of the VIPS study

Neurology, 2015-10, Vol.85 (17), p.1459-1466

2015

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease

Movement disorders, 2013-09, Vol.28 (10), p.1407-1415

Anon

2013

Volltextzugriff (PDF)

Pain and other non‐neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial

American journal of hematology, 2013-11, Vol.88 (11), p.932-938

2013

Volltextzugriff (PDF)

Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload

British journal of haematology, 2015-04, Vol.169 (2), p.262-266

2015

Volltextzugriff (PDF)

End-stage renal disease in people with type 2 diabetes: systemic manifestations and exercise implications

Physical therapy, 2004-05, Vol.84 (5), p.454-463

2004

Volltextzugriff (PDF)

Effects of Chronic Transfusions on Abdominal Sonographic Abnormalities in Children with Sickle Cell Anemia

The Journal of pediatrics, 2012-02, Vol.160 (2), p.281-285.e1

2012

Volltextzugriff (PDF)

Supplementation of infant formula with long-chain polyunsaturated fatty acids does not influence the growth of term infants

The American journal of clinical nutrition, 2005-05, Vol.81 (5), p.1094-1101

2005

Volltextzugriff (PDF)

Formative Research of a Quick List for an Automated Self-Administered 24-Hour Dietary Recall

Journal of the American Dietetic Association, 2007-06, Vol.107 (6), p.1002-1007

2007

Volltextzugriff (PDF)

A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma

Investigational new drugs, 2003-11, Vol.21 (4), p.473-480

2003

Volltextzugriff (PDF)

New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association

JAMA : the journal of the American Medical Association, 1989-05, Vol.261 (17), p.2517

1989

Volltextzugriff (PDF)

Phase II trial of docetaxel in patients with recurrent malignant glioma : a study of the National Cancer Institute of Canada Clinical Trials Group

Investigational new drugs, 1996-01, Vol.14 (2), p.203-206

1996

Volltextzugriff (PDF)

Self-presentational determinants of sex differences in leadership behavior

Small group behavior, 1985-05, Vol.16 (2), p.197-210

1985

Volltextzugriff (PDF)

Ice island field station: New features of Canadian Polar Margin

Eos (Washington, D.C.), 1989-09, Vol.70 (37), p.833-839

Hobson, George

1989

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)
magazinearticle
(1)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Synthesis and biological evaluation of imidazole-based small molecule antagonists of the melanocortin 4 receptor (MC4-R)

Identification of 2-{2-[2-(5-Bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1H-imidazole (ML00253764), a Small Molecule Melanocortin 4 Receptor Antagonist That Effectively Reduces Tumor-Induced Weight Loss in a Mouse Model

Selective Tolyl Carbon Alkylation Mediated by Imidazoline-Directed Lithiation

Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model

Identification of 2-{2-[2-(5-Bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1 H -imidazole (ML00253764), a Small Molecule Melanocortin 4 Receptor Antagonist That Effectively Reduces Tumor-Induced Weight Loss in a Mouse Model

Identification of 2-{2-[2-(5-bromo-2-methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1H-imidazol e (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model

Selective Tolyl Carbon Alkylation Mediated by Imidazoline-Directed Lithiation

Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size

Source‐based morphometry reveals structural brain pattern abnormalities in 22q11.2 deletion syndrome

Prioritizing Genetic Contributors to Cortical Alterations in 22q11.2 Deletion Syndrome Using Imaging Transcriptomics

Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness

Infection, vaccination, and childhood arterial ischemic stroke: Results of the VIPS study

A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease

Pain and other non‐neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial

Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload

End-stage renal disease in people with type 2 diabetes: systemic manifestations and exercise implications

Effects of Chronic Transfusions on Abdominal Sonographic Abnormalities in Children with Sickle Cell Anemia

Supplementation of infant formula with long-chain polyunsaturated fatty acids does not influence the growth of term infants

Formative Research of a Quick List for an Automated Self-Administered 24-Hour Dietary Recall

A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma

New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association

Phase II trial of docetaxel in patients with recurrent malignant glioma : a study of the National Cancer Institute of Canada Clinical Trials Group

Self-presentational determinants of sex differences in leadership behavior

Ice island field station: New features of Canadian Polar Margin

Suchergebnisse filtern